Arriving in the field of weight management therapy, retatrutide represents a different method. Different from many current medications, retatrutide works as a twin agonist, concurrently engaging both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) sensors. The simultaneous engagement fosters several beneficial